We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

193 hedge funds and large institutions have $3.92B invested in Dyne Therapeutics in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 79 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

527% more call options, than puts

Call options by funds: $6.11M | Put options by funds: $973K

124% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 21

72% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 46

45% more capital invested

Capital invested by funds: $2.71B → $3.92B (+$1.21B)

40% more funds holding in top 10

Funds holding in top 10: 10 → 14 (+4)

14% more funds holding

Funds holding: 169 → 193 (+24)

3.01% less ownership

Funds ownership: 116.41% → 113.4% (-3%)

Holders
193
Holders Change
+24
Holders Change %
+14.2%
% of All Funds
2.79%
Holding in Top 10
14
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+40%
% of All Funds
0.2%
New
47
Increased
79
Reduced
46
Closed
21
Calls
$6.11M
Puts
$973K
Net Calls
+$5.13M
Net Calls Change
+$11.2M

Top Buyers

1
RI
RTW Investments
New York
+$95.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$61M
3
Holocene Advisors
Holocene Advisors
New York
+$60.3M
4
BlackRock
BlackRock
New York
+$58M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$56.6M

Top Sellers

1
MAM
MPM Asset Management
Massachusetts
-$54.9M
2
LGM
Logos Global Management
California
-$42.6M
3
State Street
State Street
Massachusetts
-$28.8M
4
DTC
Deep Track Capital
Connecticut
-$16.1M
5
NCM
Nantahala Capital Management
Connecticut
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$283M – – –
FIS
2
FCPM III Services
Netherlands
$277M – – –
BlackRock
3
BlackRock
New York
$261M +$58M +1,996,946 +37%
RI
4
RTW Investments
New York
$225M +$95.8M +3,295,551 +107%
RCM
5
RA Capital Management
Massachusetts
$213M +$31.8M +1,094,425 +22%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$188M +$61M +2,100,570 +65%
Vanguard Group
7
Vanguard Group
Pennsylvania
$167M +$37.1M +1,277,784 +37%
Janus Henderson Group
8
Janus Henderson Group
United Kingdom
$163M +$56.6M +1,948,584 +73%
Citadel Advisors
9
Citadel Advisors
Florida
$152M +$1.79M +61,730 +1%
DTC
10
Deep Track Capital
Connecticut
$141M -$16.1M -555,383 -12%
Adage Capital Partners
11
Adage Capital Partners
Massachusetts
$117M +$29.1M +1,003,000 +43%
State Street
12
State Street
Massachusetts
$113M -$28.8M -992,584 -24%
TCM
13
TCG Crossover Management
California
$93.5M – – –
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$83.5M +$35.9M +1,233,977 +109%
VA
15
VR Adviser
New York
$76.7M – – –
Goldman Sachs
16
Goldman Sachs
New York
$74M +$12.6M +434,661 +26%
Holocene Advisors
17
Holocene Advisors
New York
$73.3M +$60.3M +2,076,352 New
Geode Capital Management
18
Geode Capital Management
Massachusetts
$62.6M +$13.6M +467,049 +36%
Franklin Resources
19
Franklin Resources
California
$60.5M -$2M -68,775 -4%
VC
20
Vivo Capital
California
$57.7M – – –
SI
21
Sofinnova Investments
California
$57.4M -$9.04M -310,947 -16%
MAM
22
MPM Asset Management
Massachusetts
$55.1M -$54.9M -1,889,807 -55%
AG
23
Artal Group
Luxembourg
$53.5M -$29.1K -1,000 -0.1%
Jennison Associates
24
Jennison Associates
New York
$46.8M +$3.48M +119,671 +10%
WP
25
Woodline Partners
California
$43.5M +$15.6M +535,981 +77%
1
2 3 4 5

DYN Hedge Fund Activity: Q2 2024 in Review

193 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q2 2024, worth a combined $3.92B — up 45% from $2.71B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new DYN positions and 21 closed out — a net gain of 26 holders — while 79 added to existing stakes and 46 trimmed.

The largest buyer was RTW Investments, adding an estimated $95.8M. The largest seller was MPM Asset Management, cutting an estimated $54.9M.

  • 193 institutional investors held Dyne Therapeutics (DYN) as of Q2 2024, up from 169 in Q1 2024.
  • Funds reported $3.92B of Dyne Therapeutics stock for Q2 2024, up 45% quarter-over-quarter.
  • 47 funds opened new Dyne Therapeutics positions in Q2 2024 and 21 closed out, a net change of +26 holders.
  • The largest Dyne Therapeutics buyer in Q2 2024 was RTW Investments, an estimated $95.8M added.
  • The largest Dyne Therapeutics seller in Q2 2024 was MPM Asset Management, an estimated $54.9M sold.

Based on aggregated 13F filings for Q2 2024.